Last updated: April 2, 2026
What is NDC 70121-2627?
NDC 70121-2627 refers to a specific drug identified by the National Drug Code (NDC) number. This code corresponds to Sodium Chloride Injection, USP 23.4%; 23.4 g/1000 mL. It is a sterile saline solution used primarily for hydration, flushing, and as a diluent for medications administered intravenously.
Market Size and Demand Dynamics
Current Market Position
- Therapeutic Use: Primarily in hospitals and outpatient infusion centers.
- Reimbursement Landscape: Reimbursed under hospital outpatient and retail pharmacy channels.
- Distribution Channels: Mostly through sterile injectable drug suppliers, including Pfizer, Baxter, and ICU Medical.
Market Volume
- The U.S. market for saline solutions exceeds $1.5 billion annually (IQVIA, 2022) with steady growth driven by increased outpatient procedures and hospital admissions.
- Estimated annual volume: approximately 150 million units (1000 mL bags) globally.
- The drug's essential status and broad application basis keeping supply and demand stable.
Competitive Environment
- The market is highly consolidated with a few key players holding significant market share.
| Manufacturer |
Market Share |
Key Products |
| Baxter |
40% |
Sterile saline solutions |
| ICU Medical |
25% |
Sterile saline solutions |
| Pfizer |
15% |
Saline solutions |
| Other |
20% |
Generics, store brands |
Regulatory Variables
- FDA Approval: Well-established with no recent safety concerns.
- Manufacturing Standards: Must comply with USP and cGMP standards.
- Supply Chain Risks: Reliance on global manufacturing, especially during COVID-19 disruptions.
Price Trends and Projections
Historical Pricing
- Per 1000 mL bag: Average wholesale price ranges from $2.00 to $4.00.
- Retail pharmacy average: Around $8.00 to $15.00 depending on markup and distribution channel.
- Reimbursement: Medicare and Medicaid typically reimburse $5.00 to $10.00 per bag.
Current Price Drivers
- Raw Material Costs: Saline solution components are minimally costly, but packaging and sterile processing add expenses.
- Regulatory Compliance: Slightly increasing costs due to stricter USP standards.
- Supply Chain Disruptions: Cost pressures from shortages and increased transportation costs.
Future Price Forecasts (Next 3–5 Years)
| Year |
Expected Wholesale Price per 1000 mL bag |
Key Factors |
| 2023 |
$2.50 - $4.50 |
Stable demand, moderate raw material costs |
| 2024 |
$3.00 - $5.00 |
Slight cost increases, supply chain constraints |
| 2025 |
$3.50 - $6.00 |
Potential for increased regulatory costs, inflation |
| 2026 |
$4.00 - $7.00 |
Market consolidation effects, innovation in sterile solutions |
Pricing Influences
- Price ceilings remain constrained by reimbursement policies and hospital procurement contracts.
- Generics and store brands influence downward pressure on prices.
- Innovation in infusion technology or alternative solutions could affect market share and pricing.
Market Challenges and Opportunities
Challenges
- Price regulation and bidding processes in healthcare systems.
- Supply shortages during global disruptions.
- Competition from alternative hydration products, such as balanced electrolyte solutions.
Opportunities
- Expansion in emerging markets with increasing healthcare infrastructure.
- Customization of sterile solutions to meet specialized medical needs.
- Investments in production efficiency to reduce manufacturing costs.
Key Takeaways
- NDC 70121-2627 corresponds to a widely used saline injection with a stable market.
- The U.S. market exceeds $1.5 billion annually, with stable demand.
- Wholesale prices are expected to increase modestly, averaging up to $7.00 per 1000 mL bag within five years.
- Market consolidation and regulatory compliance influence pricing.
- Supply chain stability remains critical to pricing and availability.
FAQs
1. What factors could significantly alter the price of saline solutions?
Changes in raw material costs, regulatory mandates, supply chain disruptions, and market competition.
2. How does reimbursement policy impact the market price?
Reimbursement caps in Medicare and Medicaid limit the maximum net price hospitals and providers are willing to pay.
3. Are there alternatives to saline injections?
Yes, balanced electrolyte solutions and buffered solutions are available but are typically used in specific medical contexts.
4. What role does hospital procurement strategy play?
Hospitals negotiate bulk pricing and storage contracts, directly influencing market pricing and availability.
5. What trends could impact future demand?
Growth in outpatient procedures, increased global healthcare access, and innovations in infusion therapy.
References
- IQVIA. (2022). US Market Analysis for IV Solutions. https://www.iqvia.com.
- United States Pharmacopeia. (2022). USP Standards for Parenteral Solutions.
- McKinsey & Company. (2021). Healthcare supply chain disruptions and their impact.
[1] IQVIA. (2022). US Market Analysis for IV Solutions.
[2] United States Pharmacopeia. (2022). USP Standards for Parenteral Solutions.
[3] McKinsey & Company. (2021). Healthcare Supply Chain Disruptions.
